Autus Valve Continued Access Study (CAS)
NCT: NCT07466745 · RECRUITING
Brief Summary
Prospective, single-arm, multi-center, continued access study of the Autus Size-Adjustable Valve in pediatric patients aged 18 months to 16 years requiring surgical pulmonary valve replacement. The Autus Valve may be expanded pre-implant to match the subject's body size. Subjects will be evaluated prior to the Autus Valve implant procedure, immediately post-implantation, at hospital discharge, 30 days, 6 months, and annually through 10 years. The Autus Valve may be expanded post-implant via transcatheter balloon dilation to accommodate growth of the subject.
Frequently Asked Questions
What is Autus Valve Continued Access Study (CAS)?
Autus Valve Continued Access Study (CAS) is a clinical trial registered under NCT07466745. Current status: RECRUITING.
What is the status of NCT07466745?
The current status of NCT07466745 (Autus Valve Continued Access Study (CAS)) is: RECRUITING.
When did Autus Valve Continued Access Study (CAS) start?
Autus Valve Continued Access Study (CAS) started on 2026-07-27.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.